Human Vaccines & Immunotherapeutics · 2020 · 83 citations · 26 references
Veterinary MedicineInfectious DiseasesPreventive MedicineDisease PreventionEpidemiologyImmunizationVaccinationVaccination PolicyVaccine EfficacyVaccine PolicyVaccine SafetyVaccine-preventable DiseasesAsymptomatic Infection EpidemiologyCovid-19 Vaccination In PregnancyCovid-19 Vaccination PolicyEffectiveness Against Asymptomatic InfectionEfficacy Against Severe DiseasePriority Setting In VaccinationVaccination PrioritizationVaccine Prioritization Policy
The development of COVID-19 vaccines is occurring at a rapid pace, with the potential for a vaccine to be available within 6 months. So who should be prioritized for vaccination when in the first instance, there will be insufficient supply to meet demand? There is no doubt that health-care workers in all settings should be vaccinated first, but who comes next will be a complex decision based on local epidemiology, societal values, and the ability of the vaccines to prevent both severe disease and to reduce transmission thereby eliciting herd protection. The decision on who to vaccinate should be equitable, highly contextualized, and based on the property of each vaccine. In some settings, the elderly may be prioritized, in others, it may be the population most likely to get infected and responsible for community spread. To support decision-making on who to be prioritized for vaccination requires urgent additional research on the epidemiology of COVID-19; preexisting immunity and who is responsible for transmission in a variety of settings; the safety, immunogenicity, and efficacy of COVID-19 vaccines in children and pregnant women; and determining whether COVID-19 vaccines prevent asymptomatic infection and transmission.
26
Factors associated with COVID-19-related death using OpenSAFELY
Elizabeth Williamson, Alex J Walker, Krishnan Bhaskaran et al. · Nature · 2020 · 6.7K citations · Full text
Veterinary Medicine, Infectious Diseases, Clinical Epidemiology +6
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Lisa A. Jackson, Evan J. Anderson, Nadine Rouphael et al. · New England Journal of Medicine · 2020 · 3.5K citations · Full text
Pedro M. Folegatti, Katie Ewer, Parvinder K. Aley et al. · The Lancet · 2020 · 2.6K citations · Full text
Camille Maringe, James Spicer, Melanie Morris et al. · The Lancet Oncology · 2020 · 1.9K citations · Full text